$MED

if i play stuff where i have med term outlook its hard to send a signal as people would need to be a touch more educated on trading to actually understand the trade

why don't you regulated it under family office or med-size cap fund?

**@CNBC:** This 26-year-old med student has over $350,000 in student loans—here's why she won't use a credit card. (via @CNBCMakeIt) https://t.co/0a9CWFe2GL https://twitter.com/CNBC/status/1509231065617125378

Poco fa leggevo questo: "Margini di raffinazione Med in calo nell’ultima settimana, con EMC benchmark a +0,70 dollari barile da -0,90 dollari barile precedente. Media febbraio pari a 0,0 dollari barile, dopo gennaio a +0,3 dollari barile. Il quarto trimestre 2021 è stato pari a +1,2 dollari barile, dopo un terzo trimestre pari a +1 dollari barile." > @tradando said: Renato una domanda su saras come mai con un greggio a100 dollari al barile continua a salire nn dovrebbe impattare sui margini di raffinazione, forse e' stata chiusa qualche posizione short ?

Concentrating it into big tech amzn googl msft, some beat up growth like Ddog axon veev ttd CRWD Se and some high quality med equipment like Wst STE TMO little more inmd

med. please

My med friends update me everyday on the covid patient situation....they see the cases start to decrease.........

🤔 > @Benlax said: yea can't go wrong with med tech

yea can't go wrong with med tech

this is a good time to look at med tech names guys

was wondering why med tech was getting hit hard

Wednesday, August 4, 2021 Futures Up/Down % Last Dow -25.00 0.07% 34,973 S&P 500 -1.25 0.04% 4,413 Nasdaq 11.50 0.08% 15,058 U.S. S&P futures are flat heading into the trading day, looking to build on record highs from Tuesday as positive earnings boost U.S and European stocks while worries over China’s gaming and technology crackdown ease, helping lift those markets. Risk sentiment improves across Asia as Chinese and Hong Kong stocks push higher on tech recovery and solid Caixin PMI data. In Asian markets, The Nikkei Index fell -57 points to 27,854, the Shanghai Index rose 29 points to 3,477 and the Hang Seng Index jumped 231 points to settle at 26,426. In Europe, the German DAX is climbing around 125 points to 15,680, while the FTSE 100 is up 0.4% to 7,135. Chinese Jul Caixin Services PMI beat: 54.9 vs 50.6 consensus. Some also see the spread of the Covid-19 delta variant as delaying rather than stopping the economic recovery. The New York Times reported overnight that the FDA plans to give full approval to Pfizer (PFE) and BioNTech (BNTX) coronavirus vaccine by the start of the next month. Earnings season has been strong with about 87% of S&P 500 companies reporting earnings and revenue beats, according to FactSet. Just under 70% of the S&P 500 now has reported earnings. The S&P 500 closed at record highs with gains in Apple and healthcare stocks, as concerns over a surge in the Delta variant of the coronavirus was put to the back-burner, overshadowed by continued upbeat corporate earnings. Ten of the 11 S&P indexes traded higher, with energy stocks rebounding after getting hit by a dip in oil prices. Market Closing Prices Yesterday The S&P 500 Index gained 35.99 points, or 0.82%, to 4,423.15 The Dow Jones Industrial Average rose 278.24 points, or 0.80%, to 35,116.40 The Nasdaq Composite climbed 80.23 points, or 0.55%, to 14,761.29 The Russell 2000 Index advanced 8.09 points, or 0.36% to 2,223.58 Events Calendar for Today 7:00 AM ET MBA Mortgage Applications Data 8:15 AM ET ADP Employment Change for July…est. 695K 9:45 AM ET Markit Composite PMI, July-F 9:45 AM ET Markit Services PMI, July-F 10:00 AM ET ISM Non-Manufacturing Services PMI for July…est. 60.5 10:30 AM ET Weekly DOE Inventory Data Earnings Calendar: Earnings Before the Open: ABC, AEIS, ALE, APO, ASTE, BCOR, BDC, BGCP, BWA, CDW, CLVS, CLH, CLW, CMLS, CRL, CSII, DNOW, DOC, EDIT, EMR, ETR, EXC, FLOW, FUN, GEL, GM, HDSN, HFC, HZNP, IONS, JLL, KHC, LL, MAC, MKL, MPC, MPLX, MTOR, NI, NYT, ODP, RCL, SBGI, SGRY, SITE, SMG, SPR, SUP, TGI, TUP, TXMD, UTHR, VCEL, VMC, WLL Earnings After the Close: ACAD, ACLS, ADPT, ADTN, AGL, ALB, ALL, AMED, ANGI, ANSS, APA, ATO, AXGN, BBSI, BE, BFAM, BKNG, BOOT, CCMP, CDAY, CENX, CHNG, CMP, CPS, DGII, DOX, DVAX, DXC, EA, EGHT, ELF, EMKR, EOG, ETSY, EVH, FLT, FOXA, FSLY, FTDR, GDDY, GNK, HI, HUBS, IAC, INGN, IVR, JACK, LESL, LNC, LPI, LUMN, MAXR, MBI, MCK, MED, MET, MGM, MOD, MRO, MTG, NUS,NVRO, ONEM, PARR, PDCE, $PING, PLYA, QRVO, QTWO, RCII, REGI, RGR, RMAX, RNWK, EOKU, RPD, $RVLV, RYN, SBRA, SMSI, SUM, T$NDM, TPC, TTGT, TVTY, TWNK, TWO, TXG, $UBER, UHAL, VVV, VZIO, WDC, WU, YELL Other Key Events: Jefferies Industrials Conference (virtual), 8/3-8/4 Piper Wealth Management Forum (virtual), 8/3-8/6 Macro Up/Down Last Nymex -0.34 70.22 Brent -0.18 72.23 Gold 3.30 1,813.75 EUR/USD -0.0008 1.1856 JPY/USD 0.13 109.17 10-Year Note +0.008 1.182% Sector News Breakdown Consumer Caesar’s Entertainment ($CZR) Q2 EPS $0.34 vs. est. loss (-$0.26); Q2 revs $2.5B vs. est. $2.27B; Q2 same-store Adjusted EBITDA was $1B versus (-$131M) for the comparable prior-year period; Company posted all-time records in quarterly Adjusted EBITDA and Adjusted EBITDA margin. Denny’s ($DENN) Q2 adj EPS $0.18 vs. est. $0.11; Q2 revs $106.2M vs. est. $98.1M; Q2 domestic system-wide same-store sales decreased 1.2% compared to the equivalent fiscal period in 2019, including a 1.5% decrease at domestic franchised restaurants and a 1.9% increase at company restaurants. Herbalife ($HLF) Q2 adj EPS $1.52 vs. est. $1.29; Q2 revs $1.55B vs. est. $1.57B; Q2 adjusted EBITDA of $262.1M; raises FY21 EPS view to $4.70-$5.10 from $4.65-$5.05 (est. $4.93); sees FY net sales growth to be in a range of 8.5% to 12.5%, lowering the midpoint by 150 basis points compared to prior full year 2021 guidance. Host Hotels ($HST) Q2 adj FFO $0.12 vs. est. $0.04; Q2 revs $649M vs. est. $606.58M; said RevPAR reached nearly $100 for the quarter, which dramatically outperformed consensus RevPAR, with average room rates only 8.4% below our 2019 second quarter rates; not providing year guidance Hyatt ($H) 2Q adj EPS ($1.15) vs est. ($0.85) on comparable system-wide REVPAR $72.47, qtrly total revs $663Mm vs est. $686.9Mm; guides FY net rooms growth more than +6%, sees FY adj SG&A about $240Mm, sees FY CAPEX about $110Mm Energy Devon Energy ($DVN) Q2 adj EPS $0.60 vs est. $0.52 on revs $2.42B vs est. $2.35B, operating cash flow $1.1B, production for the quarter averaged 291k barrels/day; will pay total dividend of 49c/shr (11c fixed + 38c variable), a 44% increase from Q1; sees 3q production 566-594 mboe/d vs est. 564.80 mboe/d Occidental Petroleum ($OXY) Q2 adj EPS 32c vs est. 1c on revs $5.96B vs est. $5.92B, FCF $2B, cash flow from continuing operations $3.3B; said oil and gas results improved from Q1 due to higher commodity prices and sales volumes; executed debt tender offer and repaid over $3B of long-term debt in July ONEOK ($OKE) Q2 EPS $0.77 vs. est. $0.75; Q2 revs $3.39B vs. est. $3.03B; sees 2021 net income, adj earnings before interest, taxes, depreciation, amortization to be above midpoints of ranges provided on April 27, 2021 SunPower ($SPWR) Q2 adj EPS $0.06 vs. est. $0.04; Q2 revs $308.9M vs. est. $327.31M; guides Q3 revs $325M-$375M vs. est. $400.83M; sees Q3 GAAP net loss of $10 to $0 million and MW recognized of 125 MW to 150 MW; Q2 added 13,000 residential customers – residential bookings up 16 percent sequentially, 67 percent year-over-year (YoY) The American Petroleum Institute ($API) showed a draw of 879K barrels of oil for the latest week; gasoline inventories show a draw of 5.75M barrels, distillate inventories show a draw of 717K barrels and Cushing inventories show a build of 659K barrels W&T Offshore ($WTI) Q2 EPS $0.02 vs. est. $0.07; Q2 revs $132.8M vs. est. $122.38M; Q2 Production was 40,888 Boe/d or 3.7 MMBoe, an increase of 3% compared to 39,657 Boe/d in Q1 and down 3% versus 42,037 Boe/d in Q2 of 2020 Financials Assurant Inc. ($AIZ) Q2 operating EPS $2.99 vs. est. $2.45; Q2 revs $2.54B vs. est. $2.39B; continue to expect to grow eps, ex. catastrophes, by 10 to 14 percent for 2021 Fair Isaac ($FICO) Q3 non-GAAP EPS $3.38 vs. est. $2.76; Q3 revs $338M vs. est. $328.3M; Applications revenues, which include the company’s decision management applications and associated professional services, were $133.2 million in the third quarter, compared to $141.5 million in the prior year period, a decrease of 6% Genworth Financial ($GNW) Q2 adj EPS $0.38 vs. est. $0.22; Q2 revs $2.04B vs. est. $1.9B; planned IPO of Enact remains a key strategic objective for Genworth and is subject to market and other conditions, however because the company is in registration and subject to applicable publicity restrictions, is unable to comment further or provide any additional detail at this time. Green Dot ($GDOT) Q2 adj EPS $0.68 vs est. $0.43 on revs $369.4M vs est. $313.2M; sees FY21 adj EPS $2.13-$2.27 vs prev. $2.06-$2.15, revs $1.33B-$1.35B vs est. $1.28B Prudential ($PRU) Q2 adj EPS $3.79 vs. est. $3.02; qtrly book value per common share of $160.31 versus $165.53 per share for year-ago; qtrly adjusted book value per common share of $104.39 versus $92.07 per share for year-ago; qtr end assets under management of $1.730 trillion versus $1.605 trillion for year-ago; now expect to return a total of $11.0B to holders from $10.5B prior Tanger Outlets ($SKT) 2Q core FFO/shr $0.43 vs est. $0.28, portfolio occupancy was 93% on June 30 vs 91.7% on March 31, avg tenant sales productivity was $424/sq ft for 12 months ended June 30 +7.3% yr/yr; guides FY FFO/shr $1.52-1.59 vs est. $1.46 Unum Group (UNM) Q2 adj EPS $1.39 vs. est. $1.11; Q2 revs $2.99B vs. est. $2.96B; Full-year 2021 outlook increased; after-tax adjusted operating income per share now expected to decline 1%-3% relative to full-year 2020, compared to an expected decline of 5%-6% prior Verisk Analytics ($VRSK) Q2 adj EPS $1.17 vs. est. $1.33; Q2 revs $747.5M vs. est. $737.3M; Net cash provided by operating activities was $233.2 million, down 6.5% for the second quarter of 2021. Free cash flow, a non-GAAP measure, was $170.7 million, down 11.5% Healthcare Change Healthcare ($CHNG) shares fell over 7% on a report that the U.S. Dept. of Justice is considering a lawsuit to block the company’s $8B sale to UnitedHealth ($UNH) https://bit.ly/3yA4Etu Option Care Health ($OPCH) 18M share Spot Secondary priced at $20.25 Amgen Inc. ($AMGN) Q2 adj EPS $4.38 vs. est. $4.06; Q2 revs $6.5B vs. est. $6.43B; backs FY21 adj EPS view $16.00-$17.00 vs. est. $16.34; backs FY21 revenue view $25.8B-$26.6B vs. est. $26.04B Amid surge in new COVID-19 infections across U.S., the FDA plans to give full approval to Pfizer (PFE) – BioNTech (BNTX) coronavirus vaccine by the start of the next month, The New York Times reports The FDA classified the recent recall of some of Philips’ (PHG) ventilators as Class 1, or the most serious type of recall, saying the use of these devices may cause serious injuries or death – Reuters CVS Health ($CVS) Q2 adj EPS $2.42 vs. est. $2.06; Q2 revs $72.62B vs. est. $70.11B; raises FY21 adjusted EPS view to $7.70-$7.80 from $7.56-$7.68 (est. $7.66); sees FY21 cash flow from operations $12.5B-$13B DaVita Inc. (DVA) 2Q EPS $2.64 vs est. $2.17; says total US dialysis treatments for 2Q were 7,413497 (avg 95,045/day); guides FY adj EPS $8.80-9.40 vs est. $8.63, sees FY adj op income $1.8-1.875B vs est. $1.816B Inspire Medical ($INSP) 2Q EPS ($0.48) vs est. ($0.64) on revs $53Mm vs est. $43.9Mm; guides FY revs $210-213Mm vs est. $195.9Mm, sees FY gr mgn 85-86%, sees opening 48-52 new US medical centers per qtr for 2H Jazz Pharma ($JAZZ) Q2 adj EPS $3.90 vs. est. $3.42; Q2 revs $751.8M vs. est. $735.62M; reaffirms FY21 non-GAAP EPS view $13.40-$14.70 (est. $14.45) and also back FY21 revenue view $3.020B-$3.180B vs. est. $3.11B; as of June 30, cash, cash equivalents were $891.4 mln, and outstanding principal balance of co’s long-term debt was $7.1 bln

maybe shouldve stuck with ew, best strength in large cap med equip

good spot to get a starter, qual growth med tech name

TMDX featured on chicago med show

I agree tho Med - LT horizon gold will go up and i'm bullish on it

I never had the flu vax and not a fan of this one either. But due to med condition, I am being told I need to

med tech and social names looking good, maybe be a little less of a battle than the pure tech growth names

USDTRY daily- as i indicated with the weekend news... a mess in TRY is upon us... in thin Asia Trade we took USDTRY up into the 8.50's a drop of around 15% vs the Friday close.. as liquidity comes back with the European open.. we had a move down to 7.7200.. the Turkish Fin Minister tried to keep things calm and promises similar policies which is a joke.. as the CB head got fired for a reason and the new head Sahap Kavcioglu is known for an advocate of low rates... we have seen a sell off to 7.7200 area but right back to 7.9000.. would think quite a few TRY longs still heading for the exit... short term, hard to say where we are heading.. med term... more TRY weakness as yet again Erdogan has missjudged the situation and the risk of further TRY devaluation is quite high... Real Money can no longer invest in Turkey... too instable..

USDJPY WEEKLY- THE CHART OF THE MOMENT.. SECOND TIME NOW THAT USDJPY IS GETTING TO THAT BIG MULTY YEAR TREND LINE RESISTANCE.. AND IT IS FRIDAY.. NICE FOR A WEEKLY CHART... ALL ABOUT THIS 109.00-10 LEVEL INTO THE CLOSE TONIGHT.... A CLOSE ABOVE THIS LEVEL WOULD INDEED OPEN A MED TERM MOVE BACK TO 114.00 MIGHT NOT HAPPEN IN A HURRY BUT WORTH FOCUSING ON

I am aware of the two meds which are slow absorbing meds. I wonder how many glaucoma patients will want to have an injection of the Travatan slow absorbing pellet into their AC. I can see where the huge advantage of injecting and antiVEGF pellet into the AC for wet SMD since these people get needle stuck in eye every 6 weeks or so. My take is it would be OK as a speculative stock. It's down from it's 52 week high of 24ish but still up big from the 52 week low of 4ish. Market cap of $1.4 billion. The slow release med technology is interesting. Just wonder how much insurance will be willing to pay for the glaucoma/dry eye pellets. It has possibilities. I am not in the stock but I will now watch it and may buy a little myself.. john

i have a meeting with a prospective pharma/med devices client soon

That's max aggression (meaning high discrimination) and med. sensitivity, meaning more buy/sell signals can come through. That's a 5-min, but am not sure of its accuracy (having done NO backtesting on $GE).

$FTCH 21.1% $DELL 9.0% $SHAK 11.2% $RUN 19.0% $MNST 6.3% $LOW 5.4% $JMIA 19.0% $OSTK 15.5% $TJX 5.4% $PLUG 17.0% $DPZ 6.8% $W 13.5% $MED 16.5% $LI 10.5% $PLAN 15.1% $NTES 7.6% $BHC 7.8% $SITE 10.5%

Look also at Mind Med (MMEDF) they make psychedelic drugs but about to get FDA approval

seems like a great spec med tech name, only 500m

nvcr is a high growth med tech, gwph is a super underpriced but doesnt get much love has a few approved drugs most notably the only fda approved cbd drug, alny has a bunch of approved rna thearuptics and is still pretty cheap so good play on genetics

should keep an eye on these med tech names into conference

Es ist Prof. Dr. Dr. med. Enrico Edinger, einziger Weltraummediziner in Deutschland.

seen alot of these > @Pyrognosis said: This morning walking the dog, we have a med clinic and there was a line around the block for COVID tests.

This morning walking the dog, we have a med clinic and there was a line around the block for COVID tests.

haven't heard from $REGN they have covid med - stock is down

med student

N.KOREA EXECUTED MISSING SOUTH KOREAN AT SEA, POURED OIL AND BURNED THE BODY -- MED

med tech, defense, retail quickly creeping up everyday while everyone focuses on tech

bro i loaded (well med pos) when we first talked about it in the personal acct

ovvio che ora dovrà stornare, sino alla med.48 ma poi seguira il cammino

Tele med space on 🔥

Greece and Turkey are rattling sabers over NG exploration in the Med Sea

lol yeah med has made out like bandits during the virus. saw a report a couple weeks ago showing that nyc paid out half of the 100 million dollar bill for one of the overflow hospitals

med tech space is almost always hot

so go grab your med supplies

do a med checkup if you have any forms of heart issues